Literature DB >> 10190832

Adult emergency visits for chronic cardiorespiratory disease: does dyspnea matter?

M B Parshall1.   

Abstract

BACKGROUND: Dyspnea is among the most common reasons for emergency department (ED) visits, yet little is known about how it is associated with visit characteristics and disposition or about how such associations differ across diagnoses.
OBJECTIVES: To characterize ED visits for chronic cardiorespiratory diseases in which dyspnea is a prominent symptom. Visit demographics and relations among reasons for presenting, visit urgency, medications, and visit disposition were examined.
METHODS: Data for this cross-sectional descriptive-exploratory study came from the 1992 National Hospital Ambulatory Medical Care Survey. All adult ED visits in the dataset for asthma (n = 395), chronic obstructive pulmonary disease (COPD; n = 239), and congestive heart failure (CHF; n = 320), as well as for mixed and restrictive chronic lung diseases (n = 18 and n = 14, respectively), were analyzed.
RESULTS: Dyspnea was the most common reason for ED visit across diagnoses, and was associated with an approximate twofold increase in likelihood of admission for patients with COPD (odds ratio [OR] = 1.9, p < .04), and, controlling for age, CHF (OR = 1.7, p = .035). Dyspnea, alone or controlling for age, did not significantly increase the likelihood of admission for asthma. However, across all diagnoses, dyspnea was associated with a two- to threefold increase in the likelihood of receiving intravenous (i.v.) fluids (p < or = .006), whereas receiving an i.v. markedly increased the likelihood of admission (OR = 10.0, p < .0001 for COPD; OR = 10.2, p < .0001 for asthma; and OR = 3.8; p < .0001 for CHF). Age independently predicted admission for asthma and CHF, but not COPD. The percentage of nonurgent visits resulting in admission was markedly higher for COPD (19%) and CHF (41%) than for asthma (4%) or adult visits in general (6%).
CONCLUSIONS: Reports of dyspnea increased the likelihood of admission from the ED either directly or indirectly, depending on diagnosis. Judgments of nonurgency may be less dependable in ED visits for COPD and CHF than for asthma or adult visits generally.

Entities:  

Mesh:

Year:  1999        PMID: 10190832     DOI: 10.1097/00006199-199903000-00004

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  7 in total

1.  Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD.

Authors:  Bridget F Collins; Laura C Feemster; Seppo T Rinne; David H Au
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

2.  Validation of a three-factor measurement model of dyspnea in hospitalized adults with heart failure.

Authors:  Mark B Parshall; Adam C Carle; Unchalee Ice; Robert Taylor; Joyce Powers
Journal:  Heart Lung       Date:  2011-07-27       Impact factor: 2.210

3.  A Bayesian Approach for Learning Gene Networks Underlying Disease Severity in COPD.

Authors:  Elin Shaddox; Francesco C Stingo; Christine B Peterson; Sean Jacobson; Charmion Cruickshank-Quinn; Katerina Kechris; Russell Bowler; Marina Vannucci
Journal:  Stat Biosci       Date:  2016-10-28

4.  Impact of blunted perception of dyspnea on medical care use and expenditure, and mortality in elderly people.

Authors:  Satoru Ebihara; Kaijun Niu; Takae Ebihara; Shinichi Kuriyama; Atsushi Hozawa; Kaori Ohmori-Matsuda; Naoki Nakaya; Ryoichi Nagatomi; Hiroyuki Arai; Masahiro Kohzuki; Ichiro Tsuji
Journal:  Front Physiol       Date:  2012-07-04       Impact factor: 4.566

5.  Breathlessness and presentation to the emergency department: a survey and clinical record review.

Authors:  Ann Hutchinson; Alistair Pickering; Paul Williams; J Martin Bland; Miriam J Johnson
Journal:  BMC Pulm Med       Date:  2017-03-20       Impact factor: 3.317

6.  Prospectively collected characteristics of adult patients, their consultations and outcomes as they report breathlessness when presenting to general practice in Australia.

Authors:  David C Currow; Katherine Clark; Geoffrey K Mitchell; Miriam J Johnson; Amy P Abernethy
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

7.  Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.

Authors:  Miriam J Johnson; Sarah Cockayne; David C Currow; Kerry Bell; Kate Hicks; Caroline Fairhurst; Rhian Gabe; David Torgerson; Laura Jefferson; Stephen Oxberry; Justin Ghosh; Karen J Hogg; Jeremy Murphy; Victoria Allgar; John G F Cleland; Andrew L Clark
Journal:  ESC Heart Fail       Date:  2019-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.